Abstract:Introduction: Porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV) are major intestinal coronaviruses that cause vomiting, diarrhea, dehydration, and mortality in piglets. These viruses coexist and lead to significant economic losses in the swine industry. Virus-like particles (VLPs) have emerged as promising alternatives to conventional inactivated vaccines due to their exceptional safety, efficacy, and ability to provide multi-disease protection with a single dose. Methods: Our study focused on specific antigenic epitopes from the PEDV S protein (SS2 and 2C10 regions) and the TGEV S protein (A and D sites) as target candidates. These epitopes were integrated into the ADDomer framework, and we successfully generated recombinant proteins AD, AD-P, AD-T, and AD-PT using the baculovirus expression vector system (BEVS). By meticulously optimizing conditions in High Five cells, we successfully expressed and purified the recombinant proteins. Subsequently, we developed the recombinant ADDomer-VLP vaccine and conducted a comprehensive evaluation of its efficacy in piglets. Results: Following ultrafiltration concentration and sucrose gradient centrifugation purification, the recombinant proteins self-assembled into VLPs as observed by transmission electron microscopy (TEM). Administration of the vaccine did not result in any adverse reactions in the immunized piglets. Additionally, no significant instances of fever were detected in any of the experimental groups, and there were no notable changes in average daily weight gain compared to the control group that received PBS. The recombinant ADDomer-VLP vaccines demonstrated strong immunogenicity, effectively stimulating the production of neutralizing antibodies against both PEDV and TGEV. Moreover, the recombinant ADDomer-VLP vaccine induced elevated levels of IFN-γ, IL-2, and IL-4, and enhanced cytotoxic T lymphocyte (CTL) activity in the peripheral blood of piglets. Discussion: These recombinant VLPs have demonstrated the ability to induce strong cellular and humoral immune responses in piglets, making them an incredibly promising platform for the rapid and simplified development of epitope vaccines.

Adjuvant Domuz IL-12 ile Kombine Transmissible Gastroenteritis Virüs Spike Geni Taşıyan DNA Aşı Domuzlarda Bağışıklık Yanıtı İyileştirir

Porcine IL-12 plasmid as an adjuvant improves the cellular and humoral immune responses of DNA vaccine targeting transmissible gastroenteritis virus spike gene in a mouse model

CpG DNA facilitate the inactivated transmissible gastroenteritis virus in enhancing the local and systemic immune response of pigs via oral administration

Immune Responses Induced by Recombinant Bacillus Subtilis Expressing the Spike Protein of Transmissible Gastroenteritis Virus in Pigs

Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus

Construction of an Oral Vaccine for Transmissible Gastroenteritis Virus Based on the Tgev N Gene Expressed in an Attenuated Salmonella Typhimurium Vector

The N-Terminal Domain of Spike Protein Is Not the Enteric Tropism Determinant for Transmissible Gastroenteritis Virus in Piglets

Progress in Genetically Engineered Vaccines for Porcine Transmissible Gastroenteritis Virus

[Construction of Recombinant Lactococcus Lactis Expressing Porcine Transmissible Gastroenteritis Spike Glycoprotein and Analysis of Immunogenicity].

Genetic Fusions of Heat-Labile Toxoid (lt) and Heat-Stable Toxin B (stb) of Porcine Enterotoxigenic Escherichia Coli Elicit Protective Anti-Lt and Anti-Stb Antibodies

Designing a Candidate Multi-Epitope Vaccine against Transmissible Gastroenteritis Virus Based on Immunoinformatic and Molecular Dynamics

A Phase Trial of the Oral Lactobacillus Casei Vaccine Polarizes Th2 Cell Immunity Against Transmissible Gastroenteritis Coronavirus Infection

Adjuvant effect of E515-A on porcine epidemic diarrhea virus inactivated vaccine

Effects of virulent and attenuated transmissible gastroenteritis virus on the ability of porcine dendritic cells to sample and present antigen

Virus-like particle vaccines with epitopes from porcine epidemic virus and transmissible gastroenteritis virus incorporated into self-assembling ADDomer platform provide clinical immune responses in piglets

Protective Immunity of a Multivalent Vaccine Candidate Against Piglet Diarrhea Caused by Enterotoxigenic Escherichia Coli (ETEC) in a Pig Model.

Construction and Characterization of Porcine Single-Chain Fragment Variable Antibodies That Neutralize Transmissible Gastroenteritis Virus in Vitro

Efficacy and Immunogenicity of Recombinant Swinepox Virus Expressing the A Epitope of the Tgev S Protein

Evaluation of the Effect of Inactivated Transmissible Gastroenteritis Virus Vaccine with Nano Silicon on the Phenotype and Function of Porcine Dendritic Cells

Bacterial Expression of Antigenic Sites A and D in the Spike Protein of Transmissible Gastroenteritis Virus and Evaluation of Their Inhibitory Effects on Viral Infection

Increased Neutralizing Antibody Production and Interferon-γ Secretion in Response to Porcine Reproductive and Respiratory Syndrome Virus Immunization in Genetically Modified Pigs.